Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New tyrosine protein kinase inhibitor-oligomer conjugates claimed

Nov. 18, 2010

EMA approves Cell Therapeutics' pediatric investigation plan for Pixuvri

Nov. 17, 2010

InteRNA Technologies receives grant from Dutch government to develop miRNA-based therapeutics

Nov. 17, 2010

Infinity Pharma advances phase Ib/II IPI-926 trial in pancreatic cancer

Nov. 17, 2010

Albert Einstein College of Medicine claims new Tim16 inhibitors

Nov. 17, 2010

Wyeth describes new PI3K-alpha/gamma and mTOR inhibitors

Nov. 17, 2010

Merrion Pharma plans phase III study of Orazol in breast cancer

Nov. 16, 2010

Agios Pharma claims new activators of pyruvate kinase isozymes M1/M2

Nov. 16, 2010

FDA approves Eisai's Halaven for late-stage breast cancer

Nov. 16, 2010

Karus Therapeutics claims new histone deacetylase inhibitors

Nov. 16, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...